News
+4
Dec 3, 2025
•
3 min read
The collaboration could aid insulin delivery for people who require higher doses and extend wear time. Trials are expected to begin in 2026.
CGM
+2
Dec 1, 2025
I spoke with CDCES Gary Scheiner about how to take full advantage of continuous glucose monitor settings and alerts for the strongest diabetes management.
All Access
+1
Nov 28, 2025
9 min read
Upgraded algorithms, a universal pod, longer wear, and a fully closed loop future—here’s what’s coming for Omnipod users in 2026, 2027, and beyond.
Future Tech
Oct 31, 2025
A new generation of glucose monitors are in development — from long-term implantables to non-invasive sensors — promising faster, more seamless diabetes management.
+3
Oct 29, 2025
All U.S. t:slim X2 users have access to FreeStyle Libre 3 Plus CGM integration, with international early-access programs rolling out later this year.
Oct 26, 2025
2 min read
Our first Diabetech Live brought the community together for an interactive deep dive into the latest insulin pump and CGM updates now and further in the fututre, as well as a sneak peek at what’s next for Diabetech.
Oct 22, 2025
1 min read
Hang out with us live as we cover the latest diabetes tech innovations from pumps, and CGMs to algorithms, plus ask YOUR questions!
Podcast
Oct 13, 2025
I sat down with two users of the twiist AID system to hear what they like and dislike about the new system and if they will continue using it.
Medtronic
Sep 23, 2025
The continuous glucose monitor built by Abbott and distributed by Medtronic is officially available for order on Medtronic's website.
Aug 18, 2025
From AI-powered care to breakthroughs in pumps and cures, this year’s conference proved diabetes education is more essential than ever.
4 min read
Tandem’s SteadiSet 7-day infusion set received FDA 510(k) clearance and is expected to release on multiple pumps next year.
Tandem Mobi
Aug 12, 2025
I’m on a mission to try every insulin pump on the market. Here’s how Tandem Mobi—and its Control-IQ+ algorithm—fit into my life over three months of daily use.
Research
Aug 11, 2025
Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
Aug 4, 2025
AI apps can already track your meals with photos and voice—soon, it’ll help manage your diabetes like a personal coach.
Jul 29, 2025
The tubeless add-on for Tandem's Mobi insulin pump will give users an untethered wear option and challenge competitors to innovate faster.
Jul 22, 2025
Tandem’s SteadiSet received FDA 510(k) clearance for 7-day wear and is expected to release in 2026 for multiple pumps.
Dexcom
Jul 21, 2025
I speak with Dexcom about recent sensor failures and receiver recalls, how the company is responding, and what’s next—including new G7 app features and the upcoming 15-day sensor.
Jul 17, 2025
The star of Black-ish opens up about his diabetes journey and shares how laughter—and a little technology—can go a long way.
Jul 14, 2025
How a T1D advocate turned a personal battle into community change—and how you can too.
+5
Jun 27, 2025
From tubeless patch pumps to fully closed-loop systems, here’s a look at the next generation of insulin pump innovation—and the companies leading the charge.
Jun 25, 2025
A new CGM deal moves PharmaSens one step closer to creating a fully self-contained insulin pump and CGM.
Beta Bionics
Jun 24, 2025
With seamless site changes and fast software iteration, Beta Bionics’ upcoming patch pump could challenge the pace and expectations of the tubeless pump market.
5 min read
The pump currently in development allows users to change sites without a phone—potentially reshaping the tubeless landscape and pushing rivals to move faster.
Travel Tips
Jun 23, 2025
My Diabetes Educator shares expert tips for traveling confidently with diabetes, from packing to navigating air travel and insulin treatment on vacation.
